We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine

Product News   Jun 17, 2011

 
BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

Univercells Technologies introduces the NevoLine™ Upstream Platform

Product News

This upstream manufacturing platform is suitable for multiple viral applications to support the booming gene therapy market and offer a cost-effective tool for rapid response to emerging infectious diseases.

READ MORE

Sartorius Releases the 4th Edition of its Live-Cell Analysis Handbook

Product News

The handbook was first launched in 2017 as a comprehensive reference guide for live-cell analysis technologies, with a focus on the complete suite of Incucyte® live-cell assays and reagents.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE